Create Account | Sign In: Author or Forum

News  |  Journals  |  Conferences  |  Opinion  |  Articles  |  Forums  |  Twitter    
Category: AIDS | Monthly Briefing

Back to Journal Articles

August 2012 Briefing - HIV & AIDS

Last Updated: September 04, 2012.


Share |

Comments: (0)




Here are what the editors at HealthDay consider to be the most important developments in HIV & AIDS for August 2012. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice.

Once-Daily Pill Approved to Treat HIV

TUESDAY, Aug. 28 (HealthDay News) -- Stribild (elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate) has been approved by the U.S. Food and Drug Administration to treat adults with HIV.

this approval

AAP: Health Benefits of Male Circumcision Outweigh Risks

MONDAY, Aug. 27 (HealthDay News) -- The health benefits of circumcision for newborn males outweigh the risks, according to a policy statement from the American Academy of Pediatrics (AAP) published online Aug. 27 in Pediatrics.

Full Text
Technical Report

Fewer Circumcisions May Increase Infections and Costs

WEDNESDAY, Aug. 22 (HealthDay News) -- The reduced rate of neonatal male circumcision (MC) procedures performed in the United States is estimated to lead to increased infection prevalence and higher medical costs for men and women, according to a study published online Aug. 20 in the Archives of Pediatrics & Adolescent Medicine.

Full Text (subscription or payment may be required)
Editorial (subscription or payment may be required)

Prevalence of TB, Hepatitis C, HIV High Among Homeless

MONDAY, Aug. 20 (HealthDay News) -- The global prevalence of tuberculosis, hepatitis C virus infection, and HIV is high among homeless people, although significant heterogeneity is seen in prevalence estimates, according to a study published online Aug. 20 in The Lancet Infectious Diseases.

Full Text (subscription or payment may be required)
Editorial (subscription or payment may be required)

Substance in Human Breast Milk Protects Against HIV Transmission

MONDAY, Aug. 20 (HealthDay News) -- High concentrations of specific human milk oligosaccharides (HMO) appear to be protective against postnatal HIV transmission, according to research published online Aug. 15 in the American Journal of Clinical Nutrition.

Full Text (subscription or payment may be required)

Clinicians Can Unintentionally Prompt Nocebo Effect

THURSDAY, Aug. 2 (HealthDay News) -- The nocebo effect, or induction of a symptom perceived as negative by sham treatment and/or the suggestion of negative expectation, may arise from suggestions by doctors and nurses, according to a study published in Deutsches Ärzteblatt International.

Full Text

Cellular Mechanisms of HIV-1 Dissemination Elucidated

THURSDAY, Aug. 2 (HealthDay News) -- HIV-1-infected T cells are motile, form syncytia, and play a key role in HIV dissemination, according to a letter to the editor published online Aug. 1 in Nature.

Full Text (subscription or payment may be required)

Copyright © 2012 ScoutNews, LLC. All rights reserved.

Previous: August 2012 Briefing - Gastroenterology Next: August 2012 Briefing - Infectious Disease

Reader comments on this article are listed below. Review our comments policy.

Submit your opinion:





Remember my personal information

Notify me of follow-up comments?


Useful Sites
  Tools & Services: Follow DoctorsLounge on Twitter Follow us on Twitter | RSS News | Newsletter | Contact us
Copyright © 2001-2016
Doctors Lounge.
All rights reserved.

Medical Reference:
Diseases | Symptoms
Drugs | Labs | Procedures
Software | Tutorials

Links | Humor
Forum Archive
CME | Conferences

Privacy Statement
Terms & Conditions
Editorial Board
About us | Email

This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information:
verify here.